Patent foramen ovale

Expert Review of Cardiovascular Therapy

Volumn 3, Issue 5, 2005, Pages 875-878

  Fu, Yu Ching ^a   Hijazi, Ziyad M ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Amplatzer; Cryptogenic stroke; Migraine; Transcatheter patent foramen ovale closure

Indexed keywords

ACETYLSALICYLIC ACID; CERIVASTATIN; CLOPIDOGREL; WARFARIN;

ARTIFICIAL EMBOLISM; BLEEDING DISORDER; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE EXACERBATION; HEART ATRIUM SEPTUM DEFECT; HUMAN; INTERMETHOD COMPARISON; MEDICAL INSTRUMENTATION; MEDICAL TECHNOLOGY; MIGRAINE; PARADOXICAL EMBOLISM; POSTOPERATIVE THROMBOSIS; REVIEW; RISK ASSESSMENT; STROKE; SURGICAL APPROACH; TRANSIENT ISCHEMIC ATTACK; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; CEREBROVASCULAR ACCIDENT; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; PROSTHESES AND IMPLANTS;

EID: 26844443878     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.3.5.875     Document Type: Review

References (31)

1. Tsimikas S. Transcatheter closure of patent foramen ovale for migraine prophylaxis: hope or hype? J. Am. Coll. Health 45, 496-498 (2005).
2. Schrader R. Indication and techniques of transcatheter closure of patent foramen ovale. J. Interv. Cardiol. 16, 543-551 (2003).
3. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin. Proc. 59, 17-20 (1984).
4. Webster MW, Chancellor AM, Smith HJ et al. Patent foramen ovale in young stroke patients. Lancet 2, 11-12 (1988).
5. Lechat P, Mas JL, Lascault G et al. Prevalence of patent foramen ovale in patients with stroke. N. Engl. J. Med. 318, 1148-1152 (1988).
6. Khairy P, O'Donnell CP, Landzberg MJ, Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann. Intern. Med. 139, 753-760 (2003).
7. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann. Intern. Med. 117, 461-465 (1992).
8. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55, 1172-1179 (2000).
9. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 107, 5-9 (2003).
10. Windecker S, Wahl A, Nedeltchev K et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J. Am. Coll. Health 44, 750-758 (2004).
11. Srivastava TN, Payment MF. Images in clinical medicine. Paradoxical embolism-thrombus in transit through a patent foramen ovale. N. Engl. J. Med. 337, 681 (1997).
12. Falk V, Walther T, Krankenherg H, Mohr FW. Trapped thrombus in a patent foramen ovale. Thorac. Cardiovasc. Surg. 45, 90-92 (1997).
13. Kessel-Schaefer A, Lefkovits M, Zellweger MJ et al. Migrating thrombus trapped in a patent foramen ovale. Circulation 103, 1928 (2001).
14. Stone DA, Godard J, Corretti MC et al. Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am. Heart J. 131, 158-161 (1996).
15. Steiner MM, Di Tullio MR, Rundek T et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 29, 944-948 (1998).
16. Schuchlenz HW, Weihs W, Horner S, Quehenberger F. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am. J. Med. 109, 456-462 (2000).
17. Stollberger C, Slany J, Schuster I, Leitner H, Winkler WB, Karnik R. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann. Intern. Med. 119, 461-465 (1993).
18. Lethen H, Flachskampf FA, Schneider R et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am. J. Cardiol. 80, 1066-1069 (1997).
19. Cramer SC, Rordorf G, Maki JH et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke 35, 46-50 (2004).
20. Agmon Y, Khandheria BK, Meissner I et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation 99, 1942-1944 (1999).
21. Mas JL, Arquizan C, Lamy C et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N. Engl. J. Med. 345, 1740-1746 (2001).
22. Telman G, Kouperberg E, Sprecher E, Goldsher D, Yarnitsky D. Distribution of artificial cerebral microemboli in stroke patients with patent foramen ovale. Neurol. Res. 27, 109-111 (2005).
23. Wu LA, Malouf JF, Dearani JA et al. Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch. Intern. Med. 164, 950-956 (2004)
24. Devuyst G, Piechowski-Jozwiak B, Karapanayiotides T et al. Controlled contrast transcranial Doppler and arterial blood gas analysis to quantify shunt through patent foramen ovale. Stroke 35, 859-863 (2004).
25. Schuchlenz HW, Weihs W, Beitzke A, Stein JI, Gamillscheg A, Rehak P. Transesophageal echocardiography for quantifying size of patent foramen ovale in patients with cryptogenic cerebrovascular events. Stroke 33, 293-296 (2002).
26. Hijazi ZM, Wang Z, Cao Q, Koenig P, Waight D, Lang R. Transcatheter closure of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance: feasibility and comparison with transesophageal echocardiography. Cathet. Cardiovasc. Interv. 52, 194-199 (2001).
27. Landzberg MJ, Khairy P. Indications for the closure of patent foramen ovale. Heart 90, 219-224 (2004).
28. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 86, 1902-1908 (1992).
29. Meier B. Closure of patent foramen ovale: technique, pitfalls, complications, and follow-up. Heart 91, 444-448 (2005).
30. Reisman M, Christofferson RD, Jesurum J et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J. Am. Coll. Health 45, 493-495 (2005).
31. Schwerzmann M, Wiher S, Nedeltchev K et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 62, 1399-1401 (2004).